[Federal Register Volume 76, Number 189 (Thursday, September 29, 2011)]
[Notices]
[Pages 60506-60507]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-25120]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0002]
Request for Notification From Industry Organizations Interested
in Participating in the Selection Process and Request for Nominations
for a Nonvoting Industry Representative on the Vaccines and Biological
Products Advisory Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting that any
industry organizations interested in participating in the selection of
a nonvoting industry representative to serve on the Vaccines and
Related Biological Products Advisory Committee for the Center for
Biologics Evaluation and Research (CBER) notify FDA in writing. FDA is
also requesting nominations for a nonvoting industry representative to
serve the Vaccines and Related Biological Products Advisory Committee.
A nominee may either be self-nominated or nominated by an organization
to serve as a nonvoting industry representative. Nomination will be
accepted for current vacancies effective with this notice.
DATES: Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests must send a letter stating that interest to the FDA by
October 31, 2011, for the vacancy listed in this document.
Concurrently, nomination materials for prospective candidates should be
sent to FDA by October 31, 2011.
ADDRESSES: All letters of interest and nominations should be submitted
in writing to Donald Jehn (see FOR FURTHER INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT: Donald Jehn, Center for Biologics
Evaluation and Research (HFM-71), Food and Drug Administration, 1401
Rockville Pike, Rockville, MD 20852-1448, 301-827-0314, FAX: 301-827-
0294, e-mail: [email protected].
SUPPLEMENTARY INFORMATION: The Agency intends to add a nonvoting
industry representative on the CBER Advisory Committee.
I. Vaccines and Related Biological Products Advisory Committee
The Vaccines and Related Biological Products Advisory Committee
(the Committee) advises the Commissioner
[[Page 60507]]
of Food and Drugs (the Commissioner) or designee in discharging
responsibilities as they relate to the regulation of vaccines and
related biological products. Members are asked to provide their expert
scientific and technical advice to FDA to help make sound decisions on
the safety, effectiveness, and appropriate use, of vaccines and related
biological products.
II. Selection Procedure
Any industry organization interested in participating in the
selection of an appropriate nonvoting member to represent industry
interests should send a letter stating that interest to the FDA contact
(see FOR FURTHER INFORMATION CONTACT and DATES). Within the subsequent
30 days, FDA will send a letter to each organization that has expressed
an interest, attaching a complete list of all such organizations; and a
list of all nominees along with their current resumes. The letter will
also state that it is the responsibility of the interested
organizations to confer with one another and to select a candidate,
within 60 days after the receipt of the FDA letter, to serve as the
nonvoting member to represent industry interests for the Committee. The
interested organizations are not bound by the list of nominees in
selecting a candidate. However, if no individual is selected within 60
days, the Commissioner will select the nonvoting member to represent
industry interests.
III. Application Procedure
Individuals may self-nominate and/or an organization may nominate
one or more individuals to serve as a nonvoting industry representative
(for the roles specified in this document). Nominations must include a
current resume or curriculum vitae of the nominee including current
business address and/or home address, telephone number, email address
if available, and the role for which the individual is being nominated.
FDA will forward all nominations to the organizations expressing
interest in participating in the selection process for the committee.
(Persons who nominate themselves as nonvoting industry representatives
will not participate in the selection process).
FDA has a special interest in ensuring that women, minority groups,
individuals with physical disabilities, and small businesses are
adequately represented on its advisory committees, and therefore,
encourages nominations for appropriately qualified candidates from
these groups.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: September 23, 2011.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2011-25120 Filed 9-28-11; 8:45 am]
BILLING CODE 4160-01-P